Emergent BioSolutions (United Kingdom)
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Emergent BioSolutions (United Kingdom), United Kingdom, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
68%
Total
Publications
63
Total Open
Publications
43
Total
Citations
786
Open Access
Percentage
68%
Total
Publications
63
Total Open
Publications
43
Total
Citations
786
Breakdown
Publisher Open
37%
Both
24%
Other Platform Open
5%
Closed
34%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 58%
21
Hybrid 22%
8
No Guarantees 20%
7
Other Platform Open
Institution 48%
10
Domain 43%
9
Public 19%
4
Other Internet 10%
2
Preprint 5%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 9 |
ORA - Oxford University Research Archive | Institution | 4 |
University of Melbourne - Minerva Access | Institution | 2 |
Open Research Library | Public | 2 |
Figshare | Public | 2 |
Elsevier - Scopus | Institution | 2 |
Unknown Repository | Other Internet | 1 |
University of Minnesota, USA - AgEcon Search | Institution | 1 |
University of KwaZulu-Natal - ResearchSpace | Institution | 1 |
Universitat Jaume I - Repositori UJI | Institution | 1 |